benzeneboronic acid has been researched along with B16 Melanoma in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 4 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, S; Feng, R; Song, Z; Wang, W; Xu, H; Zhu, L | 1 |
| Chen, M; Chen, Q; Deng, W; Gong, Y; Jin, Q; Liu, Z; Shen, J; Sun, J; Tan, Y; Wang, C | 1 |
| Fukumitsu, N; Kim, A; Matsumoto, Y; Nagasaki, Y; Suzuki, M | 1 |
| Alberti, D; Djanashvili, K; Geninatti Crich, S; Martinelli, J; Tei, L | 1 |
| Chen, J; Chen, X; Ding, J; Sun, T; Xiao, H; Xu, W; Zhuang, X | 1 |
| Hou, B; Hu, X; Lai, Y; Lei, L; Tian, Y; Wang, Y; Xu, J; Xu, Z; Yu, H; Zhang, W | 1 |
6 other study(ies) available for benzeneboronic acid and B16 Melanoma
| Article | Year |
|---|---|
Phenylboronic acid-functionalized F127-oligochitosan conjugate micelles for doxorubicin encapsulation.
Topics: A549 Cells; Animals; Antibiotics, Antineoplastic; Boronic Acids; Cell Line, Tumor; Cell Survival; Chitosan; Doxorubicin; Drug Delivery Systems; Drug Liberation; HT29 Cells; Humans; Melanoma, Experimental; Mice; Micelles; Oligosaccharides; Particle Size; Rats; Rats, Sprague-Dawley | 2020 |
Injectable Reactive Oxygen Species-Responsive SN38 Prodrug Scaffold with Checkpoint Inhibitors for Combined Chemoimmunotherapy.
Topics: Animals; Antineoplastic Agents; Boronic Acids; Cell Death; Cell Line, Tumor; Cell Proliferation; Combined Modality Therapy; Female; Immunotherapy; Irinotecan; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Molecular Structure; Particle Size; Polyvinyl Alcohol; Prodrugs; Programmed Cell Death 1 Receptor; Reactive Oxygen Species; Surface Properties; T-Lymphocytes | 2020 |
Non-isotope enriched phenylboronic acid-decorated dual-functional nano-assembles for an actively targeting BNCT drug.
Topics: Animals; Boron Compounds; Boron Neutron Capture Therapy; Boronic Acids; Humans; Melanoma, Experimental; Mice; Pharmaceutical Preparations | 2021 |
Towards Enhanced MRI Performance of Tumor-Specific Dimeric Phenylboronic Contrast Agents.
Topics: Animals; Boronic Acids; Cell Line, Tumor; Contrast Media; Magnetic Resonance Imaging; Melanoma, Experimental; Mice | 2021 |
Receptor and Microenvironment Dual-Recognizable Nanogel for Targeted Chemotherapy of Highly Metastatic Malignancy.
Topics: Animals; Antineoplastic Agents; Boronic Acids; Cell Line, Tumor; Cell Proliferation; Cell Survival; Doxorubicin; Drug Carriers; Drug Liberation; Gels; Humans; Melanoma, Experimental; Mice; Morpholines; Nanoparticles; Neoplasm Metastasis; Particle Size; Peptides; Surface Properties; Tissue Distribution; Tumor Microenvironment | 2017 |
Bioinspired Multivalent Peptide Nanotubes for Sialic Acid Targeting and Imaging-Guided Treatment of Metastatic Melanoma.
Topics: Animals; Boronic Acids; Humans; Irinotecan; Melanoma; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Mice, Nude; N-Acetylneuraminic Acid; Nanotubes, Peptide; Topoisomerase I Inhibitors | 2019 |